مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

13
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

7
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran

Pages

  210-218

Abstract

 Background and purpose: Several studies have shown the effectiveness of Screening programs in decreasing the costs and disutility of Type-2 diabetes and related complications. As there is a growth in the incidence of Type-2 diabetes amongst the Iranian population, the Cost-effectiveness of performing Type-2 diabetes Screening tests in community pharmacies of Iran was evaluated in this study from the payer’, s perspective. The target population consisted of two hypothetical cohorts of 1000 people 40 years of age without a prior diagnosis of diabetes, for the intervention (Screening test) and no-Screening groups. Experimental approach: A Markov model was developed to evaluate the Cost-effectiveness and Cost-utility of a Type-2 diabetes Screening test in community pharmacies in Iran. A 30-year time horizon was considered in the model. Three Screening programs with 5-year intervals were considered for the intervention group. The evaluated outcomes were quality-adjusted life-years (QALYs) for Cost-utility-analysis and life-years-gained (LYG) for Cost-effectiveness-analysis. To examine the robustness of the results, one-way and probabilistic-sensitivity analyses were applied to the model. Findings/Results: The Screening test represented both more effects and higher costs. The incremental effects in the base-case scenario (no-discounting) were estimated to be 0. 017 and 0. 0004 (approximately 0) for QALYs and LYG, respectively. The incremental cost was estimated to be 2. 87 USD/patient. The estimated incremental-Cost-effectiveness ratio was 164. 77 USD/QALY. Conclusion and implications: This study indicated that Screening for Type-2 diabetes in community pharmacies of Iran could be considered highly cost-effective, as it meets the WHO criteria of the annual GDP per capita ($2757 in 2020).

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    AMIRSADRI, MOHAMMADREZA, & Torkpour, Elahe. (2023). Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), 18(2), 210-218. SID. https://sid.ir/paper/1085271/en

    Vancouver: Copy

    AMIRSADRI MOHAMMADREZA, Torkpour Elahe. Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS)[Internet]. 2023;18(2):210-218. Available from: https://sid.ir/paper/1085271/en

    IEEE: Copy

    MOHAMMADREZA AMIRSADRI, and Elahe Torkpour, “Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran,” RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), vol. 18, no. 2, pp. 210–218, 2023, [Online]. Available: https://sid.ir/paper/1085271/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button